Randomized Control Trial for Reduction of Body Weight, Body Fat Patterning, and Cardiometabolic Risk Factors in Overweight Worksite Employees in Delhi, India
Table 2
Prevalence (%) of high/abnormal values of risk factors at baseline.
Variable
Intervention
Control
Obesity
90.9
80.2
M: 91.9; F: 84.2
M:77.9; F:93.8
Sum of skinfolds (mm)
70.3
75.9
M: 67.6; F: 89.5
M: 71.7; F: 100.0
Waist circumference (cm)
93.5
84.3
M: 94.9; F: 84.2
M:82.6; F:93.8
Waist-hip ratio
91.1
90.7
M: 92.6; F:78.9
M:91.3; F:87.5
Systolic blood pressure (mmHg)
31.2
31.0
M:34.8; F:5.3
M:31.8; F: 26.7
Diastolic blood pressure (mmHg)
40.3
44.0
M: 43.7; F: 15.8
M: 48.2; F: 20
Fasting blood glucose (mg/dl)
25.7
30.6
M: 29.2; F: 0.0
M: 30.6; F:30.8
Total cholesterol (mg/dl)
33.1
29.4
M:32.3; F: 38.9
M: 32.2; F:13.3
High-density lipoprotein cholesterol (mg/dl)
56.8
63.7
M: 55.4; F: 66.7
M: 62.1; F:73.3
Low-density lipoprotein cholesterol (mg/dl)
72.3
74.5
M: 73.8; F: 61.1
M: 73.6; F:80.0
Serum triglycerides (mg/dl)
37.2
33.3
M:40.0; F:16.7
M: 35.6; F:20.0
All values in percentages. See text for definitions of abnormal values.
